☆ 4.4 Review

Platelets are a major player and represent a therapeutic opportunity in systemic lupus erythematosus

JOINT BONE SPINE (2024)

Related references

Note: Only part of the references are listed.
Review Rheumatology

New biologics and targeted therapies in systemic lupus: From new molecular targets to new indications. A systematic review

Renaud Felten et al.

Summary: Despite available therapies, persistently active and corticosteroid-dependent Systemic Lupus Erythematosus (SLE) represent a significant therapeutic challenge. This systematic review provides an updated view of targeted therapies currently in clinical development in SLE, with a special focus on the most promising ones.

JOINT BONE SPINE (2023)

Add to Collection
Article Medicine, Research & Experimental

Modeling of clinical phenotypes in systemic lupus erythematosus based on the platelet transcriptome and FCGR2a genotype

MacIntosh G. Cornwell et al.

Summary: This study investigated the platelet transcriptome in patients with SLE, finding 2290 differentially expressed genes. The study also found that a mutation in a platelet receptor gene is associated with clinical features of SLE. Additionally, a transcriptomic signature was established that can differentiate SLE patients with active disease from those with inactive disease.

JOURNAL OF TRANSLATIONAL MEDICINE (2023)

Add to Collection
Article Rheumatology

Platelet LGALS3BP as a Mediator of Myeloid Inflammation in Systemic Lupus Erythematosus

Hanane El Bannoudi et al.

Summary: Platelets from patients with SLE express increased levels of LGALS3BP, which is correlated with disease severity and clinical phenotypes. LGALS3BP induces the release of proinflammatory mediators and enhances the inflammatory response of macrophages. Therefore, LGALS3BP not only serves as a novel biomarker for SLE clinical activity, but also contributes to the pathogenesis of SLE.

ARTHRITIS & RHEUMATOLOGY (2023)

Add to Collection
Article Rheumatology

Role of Platelet-Bound C4d (PC4d) in Predicting Risk of Future Thrombotic Events in Systemic Lupus Erythematosus

Yevgeniya Gartshteyn et al.

Summary: The study found that PC4d levels in SLE patients are correlated with history of thrombosis and can assess the risk of future thrombosis events. Patients with a PC4d level above the cutoff of 13 MFI are at a higher risk of arterial thrombosis and all types of thrombosis.

ARTHRITIS CARE & RESEARCH (2023)

Add to Collection
Review Immunology

Neutrophil extracellular traps in systemic autoimmune and autoinflammatory diseases

Gustaf Wigerblad et al.

Summary: Systemic autoimmune diseases occur when the immune system fails to recognize self from non-self, resulting in significant morbidity and mortality. Neutrophils, especially the neutrophil extracellular traps they release, play a crucial role in the initiation and perpetuation of these diseases, leading to organ damage. Dysregulation of neutrophil cell death can alter autoantigens and trigger complex inflammatory responses. Studies have identified specific neutrophil subsets associated with systemic autoimmune disorders that contribute to vascular damage and oxidative stress. Advances in technology have enhanced our understanding of neutrophil biology and dysregulation. This review provides an overview of the roles of neutrophils in systemic autoimmune and autoinflammatory diseases and explores potential therapeutic targets.

NATURE REVIEWS IMMUNOLOGY (2023)

Add to Collection
Article Rheumatology

Immune thrombocytopenia with clinical significance in systemic lupus erythematosus: a retrospective cohort study of 90 patients

Mickael Roussotte et al.

Summary: Patients with SLE-associated ITPCS displayed a high rate of hematological abnormalities, especially those who experienced major bleeding events, leading to higher morbidity. Management of thrombocytopenia was diverse and multiple treatment options seemed effective.

RHEUMATOLOGY (2022)

Add to Collection
Editorial Material Pharmacology & Pharmacy

Longitudinal Analysis Suggests Epstein--Barr as Cause of Multiple Sclerosis

[Anonymous]

CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)

Add to Collection
Article Hematology

A critical evaluation of crizanlizumab for the treatment of sickle cell disease

Nabin Raj Karki et al.

Summary: Crizanlizumab, a monoclonal antibody that blocks P-selectin, shows great promise in modulating the natural history of sickle cell disease with potential pleotropic effects. Ongoing studies aim to define its role in preventing other sickle cell-related complications, non-sickle cell inflammatory states, and thrombotic disorders.

EXPERT REVIEW OF HEMATOLOGY (2022)

Add to Collection
Review Medicine, General & Internal

Recent advances in the mechanisms and treatment of immune thrombocytopenia

Drew Provan et al.

Summary: Primary immune thrombocytopenia is an autoimmune disease characterized by a reduced peripheral blood platelet count. Its clinical behavior and treatment responses vary, reflecting its complex underlying pathophysiology. Traditional immune suppression therapy has limited efficacy and affects patients' quality of life. Newer treatments, such as thrombopoietin receptor agonists, have shown high efficacy and improved patient outcomes. Understanding the underlying mechanisms of the disease has led to the development of targeted therapies.

EBIOMEDICINE (2022)

Add to Collection
Review Cell Biology

In sickness and in health: The functional role of extracellular vesicles in physiology and pathology in vivo Part I: Health and Normal Physiology

Abi G. Yates et al.

Summary: Previously considered cellular debris, extracellular vesicles (EVs) are now recognized as mediators of physiological and pathological functions in the body. They have the ability to transfer nucleic acids and proteins between distant organs, interact with target cells through their surface proteins, and play a role in health and disease through vesicle-bound lipids. EVs are crucial in the pathogenesis of diseases and the maintenance of system and organ homeostasis.

JOURNAL OF EXTRACELLULAR VESICLES (2022)

Add to Collection
Review Immunology

Fc receptors gone wrong: A comprehensive review of their roles in autoimmune and inflammatory diseases

Emilie Chalayer et al.

Summary: Systemic autoimmune and inflammatory diseases are complex and only partially understood, involving abnormalities in various components of the immune system. Antibodies, particularly autoantibodies, play a key role in autoimmunity. The interaction between antibody fragment crystallisable (Fc) and Fc receptors (FcRs) has attracted much attention recently, with potential therapeutic prospects in the future. This review comprehensively describes the roles of known FcRs in systemic autoimmune and inflammatory disorders, including rheumatoid arthritis, Sjögren's syndrome, systemic lupus erythematosus, and other related diseases.

AUTOIMMUNITY REVIEWS (2022)

Add to Collection
Article Rheumatology

Clinical and prognostic significance of antinuclear antibodies in primary antiphospholipid syndrome: A multicenter retrospective study

Laure Ricard et al.

Summary: In this study, the clinical and biological data of 195 APS patients were retrospectively analyzed, revealing that APS patients with antinuclear antibodies (ANA-positive APS) may have a more severe clinical phenotype and prognosis, without increasing the risk of developing SLE. Prospective studies with longer follow-up are needed to evaluate the effects of additional therapies in this subset of APS.

JOINT BONE SPINE (2022)

Add to Collection
Article Multidisciplinary Sciences

TLR7 gain-of-function genetic variation causes human lupus

Grant J. Brown et al.

Summary: Enhanced Toll-like receptor 7 (TLR7) signaling has been associated with human systemic autoimmune disease, but evidence of TLR7 gene variants causing lupus is lacking. In this study, researchers identified a newly described TLR7(Y264H) variant that increased sensing of guanosine and 2',3'-cGMP and was sufficient to cause lupus in mice. Enhanced TLR7 signaling was shown to drive aberrant B cell survival and the accumulation of specific B cell subsets, while deficiency of the downstream adapter protein MyD88 rescued autoimmunity and all phenotypes. The study highlights the importance of TLR7 and guanosine-containing self-ligands in the pathogenesis of lupus and suggests potential therapeutic targets.

NATURE (2022)

Add to Collection
Article Rheumatology

Thrombocytopenia in primary antiphospholipid syndrome: association with prognosis and clinical implications

Yu Shi et al.

Summary: Thrombocytopenia could independently predict recurrent thrombotic, obstetric, and severe extracriteria events.

RHEUMATOLOGY (2022)

Add to Collection
Article Hematology

Enrichment of Complement, Immunoglobulins, and Autoantibody Targets in the Proteome of Platelets from Patients with Systemic Lupus Erythematosus

Carl Petrus Linge et al.

Summary: This study found that platelets in patients with SLE have a decreased size and a specific protein profile, including immunoglobulins, complement proteins, and autoantigens. The presence of these proteins may contribute to the pathogenesis of SLE.

THROMBOSIS AND HAEMOSTASIS (2022)

Add to Collection
Article Rheumatology

Platelet- and endothelial-derived microparticles in the context of different antiphospholipid antibody profiles

Chunyan Cheng et al.

Summary: This study investigated microparticles (MPs) in patients with antiphospholipid antibodies (aPL) and found that the levels of total MPs and endothelial microparticles (EMPs) were significantly higher in triple positive patients compared to single positive patients, and were correlated with IgG antibody titers. Additionally, platelet microparticles (PMPs) were found to be the lowest in triple positive patients and inversely correlated with IgG antibody titers.

LUPUS (2022)

Add to Collection
Article Immunology

Systemic lupus erythematosus-complicating immune thrombocytopenia: From pathogenesis to treatment

Ying Jiang et al.

Summary: This article reviews the pathogenesis and treatment of immune thrombocytopenia (ITP) as a common hematological manifestation of systemic lupus erythematosus (SLE). In addition to traditional treatment methods, the article introduces new therapies and highlights the need for further research to confirm their efficacy.

JOURNAL OF AUTOIMMUNITY (2022)

Add to Collection
Article Immunology

Genetic dissection of TLR9 reveals complex regulatory and cryptic proinflammatory roles in mouse lupus

Claire Leibler et al.

Summary: In lupus, TLR9 has two protective functions: one ligand-independent and MyD88-independent function, and another ligand-dependent but MyD88-independent regulatory and MyD88-mediated proinflammatory function. These functions are B cell intrinsic and restrained differentiation into pathogenic age-associated B cells and plasmablasts. This study sheds light on the biology of endosomal TLRs.

NATURE IMMUNOLOGY (2022)

Add to Collection
Article Cell Biology

A targetable pathway in neutrophils mitigates both arterial and venous thrombosis

Lalitha Nayak et al.

Summary: Arterial and venous thrombosis are major global diseases with common mechanisms involving neutrophils. This study identified neutrophils as key effectors in thrombosis and demonstrated the feasibility of targeting them using immunoregulatory nanoparticles. Moreover, key molecular events and regulators of neutrophil activation were identified, providing potential targets for therapeutics against immunothrombosis.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Add to Collection
Article Rheumatology

Incidence and management of inflammatory arthritis in England before and during the COVID-19 pandemic: a population-level cohort study using OpenSAFELY

Mark D. Russell et al.

Summary: The impact of the COVID-19 pandemic on the incidence and management of inflammatory arthritis was analyzed using data from OpenSAFELY. The study found that the number of new inflammatory arthritis diagnoses decreased during the pandemic, but there was a smaller impact on rheumatology assessment times and DMARD prescribing in primary care than expected.

LANCET RHEUMATOLOGY (2022)

Add to Collection
Article Multidisciplinary Sciences

Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis

Kjetil Bjornevik et al.

Summary: This study suggests that multiple sclerosis may be caused by Epstein-Barr virus, with no direct association with other viral infections. These findings provide clues to the primary cause of MS.

SCIENCE (2022)

Add to Collection
Review Immunology

Proteomics and enriched biological processes in Antiphospholipid syndrome: A systematic review

Ariadna Anunciacion-Llunell et al.

Summary: Identification of differentially expressed proteins in antiphospholipid syndrome (APS) through proteomics research provides insights into the pathological mechanisms and potential clinical applications. Dysregulated proteins in APS patients are connected to cellular activation and thrombosis, highlighting the need for validation and targeted therapies for different clinical subtypes.Exploration of new autoantibodies and post-translational modifications also contribute to understanding the antigen-autoantibody recognition in APS.

AUTOIMMUNITY REVIEWS (2021)

Add to Collection
Article Hematology

The bone marrow niche from the inside out: how megakaryocytes are shaped by and shape hematopoiesis

Andrew P. Stone et al.

BLOOD (2021)

Add to Collection
Article Rheumatology

Practical management of patients on hydroxychloroquine

Christophe Richez et al.

JOINT BONE SPINE (2021)

Add to Collection
Letter Rheumatology

The impact of clopidogrel on plasma-soluble CD40 ligand levels in systemic lupus erythematosus patients: the CLOPUS phase I/II pilot study

Guillaume Vial et al.

JOINT BONE SPINE (2021)

Add to Collection
Article Cell Biology

Platelets release mitochondrial antigens in systemic lupus erythematosus

Imene Melki et al.

Summary: The study reveals that platelets release mitochondrial DNA in patients with SLE, and this process is associated with platelet degranulation and requires stimulation of platelet Fc-γ-RIIA.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Add to Collection
Review Hematology

Platelets and extracellular vesicles and their cross talk with cancer

Sophia Lazar et al.

Summary: This review provides an overview of the complex roles of platelet-derived microvesicles (PMVs) in cancer development and progression, including promoting disease progression and anti-tumor functions, as well as their effects on cancer cells and non-transformed cells in the tumor microenvironment. Additionally, PMVs play a role in coagulation, thrombosis, and interactions with inflammatory cells, but separating the effects of PMVs from platelets in cancer contexts remains a challenge.

BLOOD (2021)

Add to Collection
Article Hematology

A PSGL-1 glycomimetic reduces thrombus burden without affecting hemostasis

Daniel J. Wong et al.

Summary: P-G6, a potent P-selectin inhibitor, blocks interactions between platelets and leukocytes in the process of venous thrombosis, reducing thrombus formation without affecting hemostasis.

BLOOD (2021)

Add to Collection
Article Hematology

Platelet EVs contain an active proteasome involved in protein processing for antigen presentation via MHC-I molecules

Genevieve Marcoux et al.

Summary: Platelets not only play a role in hemostasis but also have an important function in immunity by releasing extracellular vesicles (EVs) when activated. These platelet-derived EVs (PEVs) contain the active 20S proteasome, MHC-I, and lymphocyte costimulatory molecules. PEVs contribute to adaptive immunity by cross-presentation of antigens and have privileged access to immune cells through the lymphatic system.

BLOOD (2021)

Add to Collection
Article Cell Biology

Selectins impair regulatory T cell function and contribute to systemic lupus erythematosus pathogenesis

Marc Scherlinger et al.

Summary: This study identified a P-selectin-dependent pathway in patients with systemic lupus erythematosus (SLE) and validated it as a potential therapeutic avenue. Platelets from SLE patients interacted with Treg cells via the P-selectin/PSGL-1 axis, affecting Treg cell function and suppressing immune responses. Blocking P-selectin in a mouse model of SLE improved disease features, indicating its potential as a therapeutic target.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Add to Collection
Article Immunology

Serologic markers of Epstein-Barr virus reactivation are associated with increased disease activity, inflammation, and interferon pathway activation in patients with systemic lupus erythematosus

Rebecca A. Wood et al.

Summary: SLE is a heterogeneous disease characterized by an unpredictable relapsing-remitting course. This study found that EBV reactivation was more common in SLE patients and associated with higher disease activity, as well as with the IFN-associated immune pathways.

JOURNAL OF TRANSLATIONAL AUTOIMMUNITY (2021)

Add to Collection
Article Rheumatology

Hydroxychloroquine is associated with lower platelet activity and improved vascular health in systemic lupus erythematosus

MacIntosh Grant Cornwell et al.

Summary: The study showed that the use of hydroxychloroquine (HCQ) in SLE patients is associated with decreased platelet activation and expression of related transcripts, as well as improved vascular health.

LUPUS SCIENCE & MEDICINE (2021)

Add to Collection
Article Cell Biology

Platelet surface marker analysis by mass cytometry

Thomas A. Blair et al.

PLATELETS (2020)

Add to Collection
Article Immunology

In systemic lupus erythematosus anti-dsDNA antibodies can promote thrombosis through direct platelet activation

Izabella A. Andrianova et al.

JOURNAL OF AUTOIMMUNITY (2020)

Add to Collection
Article Cardiac & Cardiovascular Systems

Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels

William A. E. Parker et al.

CARDIOVASCULAR DIABETOLOGY (2020)

Add to Collection
Article Biochemistry & Molecular Biology

Altered platelet proteome in lupus anticoagulant (LA)-positive patients-protein disulfide isomerase and NETosis as new players in LA-related thrombosis

Lena Hell et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2020)

Add to Collection
Article Medicine, Research & Experimental

P-selectin blockade ameliorates lupus nephritis in MRL/lpr mice through improving renal hypoxia and evaluation using BOLD-MRI

Liwen Zhang et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2020)

Add to Collection
Review Rheumatology

Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology

Eva Schrezenmeier et al.

NATURE REVIEWS RHEUMATOLOGY (2020)

Add to Collection
Review Hematology

Immune Thrombocytopenia in Adults: Modern Approaches to Diagnosis and Treatment

Hanny Al-Samkari et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2020)

Add to Collection
Article Hematology

Platelets Disseminate Extracellular Vesicles in Lymph in Rheumatoid Arthritis

Nicolas Tessandier et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)

Add to Collection
Article Multidisciplinary Sciences

Platelet P-selectin initiates cross-presentation and dendritic cell differentiation in blood monocytes

Patrick Han et al.

SCIENCE ADVANCES (2020)

Add to Collection
Review Hematology

Molecular and functional characteristics of megakaryocytes and platelets in aging

Orlando Esparza et al.

CURRENT OPINION IN HEMATOLOGY (2020)

Add to Collection
Review Immunology

Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014

Marc Scherlinger et al.

AUTOIMMUNITY REVIEWS (2020)

Add to Collection
Article Hematology

FcγRIIA expression accelerates nephritis and increases platelet activation in systemic lupus erythematosus

Imene Melki et al.

BLOOD (2020)

Add to Collection
Review Urology & Nephrology

Complement-Mediated Disorders in Pregnancy

Kana Amari Chinchilla et al.

ADVANCES IN CHRONIC KIDNEY DISEASE (2020)

Add to Collection
Article Cell Biology

Association of Platelet Binding to Lymphocytes with B Cell Abnormalities and Clinical Manifestations in Systemic Lupus Erythematosus

Carlos Zamora et al.

MEDIATORS OF INFLAMMATION (2019)

Add to Collection
Article Hematology

TNF-α driven inflammation and mitochondrial dysfunction define the platelet hyperreactivity of aging

Pavel Davizon-Castillo et al.

BLOOD (2019)

Add to Collection
Article Biochemistry & Molecular Biology

Platelet-derived chemokines in inflammation and atherosclerosis

Constantinos Bakogiannis et al.

CYTOKINE (2019)

Add to Collection
Letter Rheumatology

Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort

Arielle Mendel et al.

ANNALS OF THE RHEUMATIC DISEASES (2019)

Add to Collection
Article Hematology

Human low-affinity IgG receptor FcRIIA polymorphism H131R associates with subclinical atherosclerosis and increased platelet activity in systemic lupus erythematosus

Robert Clancy et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)

Add to Collection
Article Hematology

Nix-mediated mitophagy regulates platelet activation and life span

Weilin Zhang et al.

BLOOD ADVANCES (2019)

Add to Collection
Article Multidisciplinary Sciences

Anti-mitochondrial autoantibodies in systemic lupus erythematosus and their association with disease manifestations

Yann Becker et al.

SCIENTIFIC REPORTS (2019)

Add to Collection
Review Cardiac & Cardiovascular Systems

Circulating Platelets as Mediators of Immunity, Inflammation, and Thrombosis

Milka Koupenova et al.

CIRCULATION RESEARCH (2018)

Add to Collection
Article Clinical Neurology

Platelets Drive Inflammation and Target Gray Matter and the Retina in Autoimmune-Mediated Encephalomyelitis

Claretta Sonia D'Souza et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2018)

Add to Collection
Review Rheumatology

The non-haemostatic role of platelets in systemic lupus erythematosus

Petrus Linge et al.

NATURE REVIEWS RHEUMATOLOGY (2018)

Add to Collection
Article Immunology

Potential Involvement of Platelet-Derived Microparticles and Microparticles Forming Immune Complexes during Monocyte Activation in Patients with Systemic Lupus Erythematosus

Catalina Burbano et al.

FRONTIERS IN IMMUNOLOGY (2018)

Add to Collection
Article Hematology

A dichotomy in platelet activation: Evidence of different functional platelet responses to inflammatory versus haemostatic stimuli

Eleonora Petito et al.

THROMBOSIS RESEARCH (2018)

Add to Collection
Letter Rheumatology

Comment on: Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus: reply

Christian Lood et al.

RHEUMATOLOGY (2017)

Add to Collection
Article Rheumatology

New Insights on Platelets and Platelet-Derived Microparticles in Systemic Lupus Erythematosus

Marc Scherlinger et al.

CURRENT RHEUMATOLOGY REPORTS (2017)

Add to Collection
Review Hematology

Platelet interaction with activated endothelium: mechanistic insights from microfluidics

Danielle M. Coenen et al.

BLOOD (2017)

Add to Collection
Article Biochemistry & Molecular Biology

Migrating Platelets Are Mechano-scavengers that Collect and Bundle Bacteria

Florian Gaertner et al.

CELL (2017)

Add to Collection
Review Hematology

Procoagulant platelets: generation, function, and therapeutic targeting in thrombosis

Ejaife O. Agbani et al.

BLOOD (2017)

Add to Collection
Article Hematology

Activated Platelets Induce Endothelial Cell Activation via an Interleukin-1 Pathway in Systemic Lupus Erythematosus

Sokha Nhek et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)

Add to Collection
Article Biochemistry & Molecular Biology

The NLRP3 inflammasome and bruton's tyrosine kinase in platelets co-regulate platelet activation, aggregation, and in vitro thrombus formation

Pranav Murthy et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)

Add to Collection
Article Oncology

Anti-β2 glycoprotein I antibodies in complex with β2 glycoprotein I induce platelet activation via two receptors: apolipoprotein E receptor 2′ and glycoprotein I bα

Wenjing Zhang et al.

FRONTIERS OF MEDICINE (2016)

Add to Collection
Article Immunology

Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis

Satish Kumar Devarapu et al.

CLINICAL IMMUNOLOGY (2016)

Add to Collection
Article Medical Laboratory Technology

Mean Platelet Volume Could Reflect Disease Activity of Adult Patients With Systemic Lupus Erythematosus

Mingjian Bai et al.

CLINICAL LABORATORY (2016)

Add to Collection
Article Medicine, Research & Experimental

Anti-dsDNA antibodies bind to TLR4 and activate NLRP3 inflammasome in lupus monocytes/macrophages

Hui Zhang et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2016)

Add to Collection
Article Hematology

Platelet Physiology

Thomas Gremmel et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2016)

Add to Collection
Article Multidisciplinary Sciences

Microparticles in the blood of patients with systemic lupus erythematosus (SLE): phenotypic characterization and clinical associations

Fariborz Mobarrez et al.

SCIENTIFIC REPORTS (2016)

Add to Collection
Article Medicine, General & Internal

Predictors of Pregnancy Outcomes in Patients With Lupus A Cohort Study

Jill P. Buyon et al.

ANNALS OF INTERNAL MEDICINE (2015)

Add to Collection
Article Hematology

P-selectin promotes neutrophil extracellular trap formation in mice

Julia Etulain et al.

BLOOD (2015)

Add to Collection
Article Medicine, Research & Experimental

Platelet-derived HMGB1 is a critical mediator of thrombosis

Sebastian Vogel et al.

JOURNAL OF CLINICAL INVESTIGATION (2015)

Add to Collection
Article Hematology

Platelets are required for enhanced activation of the endothelium and fibrinogen in a mouse thrombosis model of APS

Valerie Proulle et al.

BLOOD (2014)

Add to Collection
Article Hematology

Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis

Milka Koupenova et al.

BLOOD (2014)

Add to Collection
Article Rheumatology

Mean platelet volume as an indicator of disease activity in juvenile SLE

Sevgi Yavuz et al.

CLINICAL RHEUMATOLOGY (2014)

Add to Collection
Article Multidisciplinary Sciences

Characterization of platelet aminophospholipid externalization reveals fatty acids as molecular determinants that regulate coagulation

Stephen R. Clark et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Add to Collection
Article Medicine, General & Internal

Platelet activation in patients with the Raynaud phenomenon

L. Polidoro et al.

INTERNAL MEDICINE JOURNAL (2012)

Add to Collection
Article Immunology

Platelets Present Antigen in the Context of MHC Class I

Lesley M. Chapman et al.

JOURNAL OF IMMUNOLOGY (2012)

Add to Collection
Article Immunology

Protective Roles for Fibrin, Tissue Factor, Plasminogen Activator Inhibitor-1, and Thrombin Activatable Fibrinolysis Inhibitor, but Not Factor XI, during Defense against the Gram-Negative Bacterium Yersinia enterocolitica

Deyan Luo et al.

JOURNAL OF IMMUNOLOGY (2011)

Add to Collection
Article Hematology

Expression and functionality of type I interferon receptor in the megakaryocytic lineage

S. Negrotto et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)

Add to Collection
Review Medicine, General & Internal

MECHANISMS OF DISEASE Systemic Lupus Erythematosus

George C. Tsokos

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Add to Collection
Article Hematology

P-Selectin-Mediated Platelet-Neutrophil Aggregate Formation Activates Neutrophils in Mouse and Human Sickle Cell Disease

Renata Polanowska-Grabowska et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)

Add to Collection
Article Hematology

Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease

Christian Lood et al.

BLOOD (2010)

Add to Collection
Article Hematology

Immature myeloid dendritic cells capture and remove activated platelets from preformed aggregates

B. Maitre et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)

Add to Collection
Article Multidisciplinary Sciences

Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle Production

Eric Boilard et al.

SCIENCE (2010)

Add to Collection
Article Cell Biology

Platelet CD154 Potentiates Interferon-α Secretion by Plasmacytoid Dendritic Cells in Systemic Lupus Erythematosus

Pierre Duffau et al.

SCIENCE TRANSLATIONAL MEDICINE (2010)

Add to Collection
Review Immunology

The SYK tyrosine kinase: a crucial player in diverse biological functions

Attila Mocsai et al.

NATURE REVIEWS IMMUNOLOGY (2010)

Add to Collection
Article Rheumatology

Immunohistochemical detection of intravascular platelet microthrombi in patients with lupus nephritis and anti-phospholipid antibodies

Maria Galindo et al.

RHEUMATOLOGY (2009)

Add to Collection
Article Rheumatology

Increased levels of circulating microparticles in primary Sjogren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity

Jeremie Sellam et al.

ARTHRITIS RESEARCH & THERAPY (2009)

Add to Collection
Article Cell Biology

Functional expression of IgA receptor FcαRI on human platelets

Kun Qian et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2008)

Add to Collection
Review Medicine, General & Internal

Mechanisms of disease: Mechanisms of thrombus formation

Bruce Furie et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Add to Collection
Article Immunology

Elevated urinary VCAM-1, P-selectin, soluble TNF receptor-1, and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus nephritis

Tianfu Wu et al.

JOURNAL OF IMMUNOLOGY (2007)

Add to Collection
Article Hematology

Human platelets can activate peripheral blood B cells and increase production of immunoglobulins

Fabrice Cognasse et al.

EXPERIMENTAL HEMATOLOGY (2007)

Add to Collection
Article Hematology

Platelet adhesion to dimeric β2-glycoprotein I under conditions of flow is mediated by at least two receptors:: glycoprotein Ibα and apolipoprotein E receptor 2′

M. T. T. Pennings et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)

Add to Collection
Article Rheumatology

Aspirin therapy and thromboxane biosynthesis in systemic lupus erythematosus

Ingrid Avalos et al.

LUPUS (2007)

Add to Collection
Article Rheumatology

Two types of autoantibody-mediated thrombocytopenia in patients with systemic lupus erythematosus

M. Kuwana et al.

RHEUMATOLOGY (2006)

Add to Collection
Article Immunology

Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases

Andreas Goules et al.

JOURNAL OF AUTOIMMUNITY (2006)

Add to Collection
Article Rheumatology

Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus

G. Ruiz-Irastorza et al.

LUPUS (2006)

Add to Collection
Article Hematology

Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis

JE Joseph et al.

BRITISH JOURNAL OF HAEMATOLOGY (2001)

Add to Collection
Article Rheumatology

A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population

CC Mok et al.

RHEUMATOLOGY (2000)

Add to Collection
Article Hematology

Comparison of platelet immunity in patients with SLE and with ITP

AH Lazarus et al.

TRANSFUSION SCIENCE (2000)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.